The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

The biggest stories of the day delivered to your inbox.

'KPop Demon Hunters' tops the animation categories. By Beatrice Verhoeven Awards Editor The Visual Effects Society (VES) has announced the winners for the 2026 VES Awards, recognizing excellence in ...

Vibrance 360 is a 7,200 square foot wellness center located in Greenvale, specializing in medical aesthetics, weight management, sexual health and comprehensive whole-body care. Under the expert ...

James Ratcliff joined GameRant in 2022 as a Gaming News Writer. In 2023, James was offered a chance to become an occasional feature writer for different games and then a Senior Author in 2025. He is a ...

Even the most brilliant strategy is without merit if employees do not understand and commit to it. Strategy implementation is seen by many as the Achilles heel of strategic management, with numerous ...

Forbes contributors publish independent expert analyses and insights. Dr. Cheryl Robinson covers areas of leadership, pivoting and careers. This voice experience is generated by AI. Learn more. This ...

Alkermes is transforming into a fully integrated biopharma, leveraging Vibrance-2 results and the Avadel acquisition for competitive advantage in sleep medicine. ALKS’s robust legacy portfolio funds ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Dany Lepage discusses the architectural ...

The Oscar race for visual effects is down to 20. With multiple sources confirming to Variety, the list of finalists includes a mix of anticipated blockbusters and franchise entries, with major studios ...

– Alixorexton is the First Oral Orexin 2 Receptor Agonist to Demonstrate Efficacy in a Large Phase 2 Study in Patients With Narcolepsy Type 2, Supporting Advancement to Phase 3 – – Alixorexton Met the ...